Blackstone, Bain agree India secondary sale

Blackstone made a reported 3x on the $112m sale of Emcure Pharmaceuticals to Bain Capital.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this